|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 129.00 GBX | +0.39% |
|
-4.44% | +0.78% |
| 02/06 | Diaceutics PLC, 2025 Earnings Call, May 26, 2026 | |
| 26/05 | Diaceutics PLC Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
Main competitors
| P/E (N) | Price to Book (N) | PEG (N) | EV / Sales (N) | EV / EBITDA (N) | EV / EBIT (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
 | - | 2.66x | - | 2.16x | 9.81x | 31.72x | -.--% | 15Cr | |
| -87.88x | 7.99x | 0.25x | 18.74x | 46.59x | -75.8x | -.--% | 4.81TCr | |
| 30.29x | 3.2x | 0.43x | 2.25x | 19.42x | 32.93x | 1.57% | 329.57Cr | |
| 90.45x | 5.87x | 1.31x | 11.61x | 18.1x | 107.47x | 0.29% | 308.36Cr | |
| 34.4x | 12.59x | 2.2x | 11.08x | 23.98x | 27.46x | 1.99% | 196Cr | |
| 28.43x | 2.33x | 3.22x | 3.8x | 15.4x | 20.02x | 0.63% | 127.94Cr | |
| -72.44x | 3.62x | 0.85x | - | - | - | 0.1% | 123.05Cr | |
| 39.43x | 7.99x | 1.24x | 16.26x | 25.23x | 27.69x | 0.59% | 116.62Cr | |
| 13.58x | 4.01x | 0.34x | - | - | - | 0.43% | 100Cr | |
| -1.36x | - | 0.17x | 4.95x | 8.09x | 93.51x | -.--% | 37Cr | |
| 25.25x | 3.2x | 1.5x | 2.77x | 8.15x | 12.99x | - | 16Cr | |
| -64.06x | 5.22x | 0.71x | 1.78x | 13.72x | -45.06x | - | 14Cr | |
| Average | 3.28x | 5.33x | 1.11x | 7.54x | 18.85x | 23.29x | 0.56% | 515.91Cr | |
| Weighted average by Cap. | -61.16x | 7.47x | 0.47x | 16.63x | 41.28x | -51.24x | 0.19% |
- Stock Market
- Stocks
- DXRX Stock
- Sector Diaceutics PLC
- Sector valuations
Select your edition
All financial news and data tailored to specific country editions
